Year: 2018
Type: review
Abstract: Astrocytes play complex roles in health and disease. Here, we review recent findings on molecular pathways that control astrocyte function in multiple sclerosis (MS) as well as new tools for their investigation. In particular, we describe positive and negative regulators of astrocyte-mediated pathogenesis in MS, such as sphingolipid metabolism and aryl hydrocarbon receptor signaling, respectively. In addition, we also discuss the issue of astrocyte heterogeneity and its relevance for the contribution of astrocytes to MS pathogenesis. Finally, we discuss how new genomic tools could transform the study of astrocyte biology in MS.
Authors: Michael A. Wheeler, Francisco J. Quintana
Institutions: Brigham and Women's Hospital, Harvard University, Broad Institute
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: National Multiple Sclerosis Society, International Progressive MS Alliance, Multiple Sclerosis Society, King Abdulaziz City for Science and Technology, National Institutes of Health, National Cancer Institute, National Institute of Allergy and Infectious Diseases, National Institute of Neurological Disorders and Stroke, National Institute of Environmental Health Sciences
Awards: G1059816375, G1122819866, G2471350242, Role of aryl hydrocarbon receptor in IL-10 producing Tr1 regulatory cells, G4012388809, Cancer Immunology Training Grant, The role of the IFNAR1/AhR signaling axis in astrocyte regulation and remediation of multiple sclerosis pathogenesis, G6959888689, G7655810703, G8090927793, Role of aryl hydrocarbon receptor in IL-10 producing Tr1 regulatory cells, G8678671723, Role and Therapeutic Value of AHR in Inflammatory Macrophages during GBM, Regulation of CNS Autoimmunity, G9000346841, Role of AHR in Dendritic Cells in the Control of CNS Autoimmunity
OpenAlex ID: W2784916464
